Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 23/04/21

Trade details

Type: Insider sale
Amount: $1,291.08
Shares · price: 348 sh · $3.71 a share
Held after: 134,906 sh
Stock: Kalaris Therapeutics KLRS
Person: Brett R. HagenChief Accounting Officer
Trade date: 23/04/19
Filed: 23/04/21
Days to filing: 2 days

Sold 0.3% of holdings

Share of holding sold: 0.3%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/20~23/05/19

Brett R. Hagen's recent trades

Brett R. HagenChief Accounting Officer
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$12.9K
1,915 sh
$12.9K
Filed 03/23
Traded 03/20
Brett R. HagenChief Accounting Officer
Planned saleKalaris Therapeutics
Planned sale
Kalaris Therapeutics
KLRS
$12.9K
1,915 sh
$12.9K
Filed 03/20
Traded 03/20
Brett R. HagenChief Accounting Officer
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$8,136
907 sh
$8,136
Filed 25/03/27
Traded 25/03/26
Brett R. HagenChief Accounting Officer
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$968
96 sh
$968
Filed 25/02/24
Traded 25/02/21
Brett R. HagenOfficer
Planned saleKalaris Therapeutics
Planned sale
Kalaris Therapeutics
KLRS
$967
96 sh
$967
Filed 25/02/24
Traded 25/02/21

Brett R. Hagen, CAO — sold $1,291 of Kalaris Therapeutics KLRS · 0.3% of holdings · 10b5-1 plan | Whalegun